These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2284248)

  • 1. Functional and binding studies on dopamine D1 receptors in districts controlling intraocular pressure.
    Daniele E; Govoni S; Lograno MD
    Pharmacol Res; 1990; 22 Suppl 1():55-6. PubMed ID: 2284248
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and functional evidence for the presence of dopamine D1 receptors in the bovine ciliary body.
    Lograno MD; Daniele E; Govoni S
    Exp Eye Res; 1990 Nov; 51(5):495-501. PubMed ID: 1979033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393.
    Scatton B; Dubois A
    Eur J Pharmacol; 1985 Apr; 111(1):145-6. PubMed ID: 3874779
    [No Abstract]   [Full Text] [Related]  

  • 7. D1/D2 dopamine receptor interaction at the biochemical level.
    Strange PG
    Trends Pharmacol Sci; 1991 Feb; 12(2):48-9. PubMed ID: 1850879
    [No Abstract]   [Full Text] [Related]  

  • 8. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393.
    Smiałowski A
    Brain Res; 1990 Sep; 528(1):148-50. PubMed ID: 2147120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission.
    Scatton B
    Life Sci; 1982 Dec; 31(25):2883-90. PubMed ID: 6298532
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
    Pettersson I; Gundertofte K; Palm J; Liljefors T
    J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
    Denis P; Elena PP; Nordmann JP; Saraux H; Lapalus P
    Neurosci Lett; 1990 Aug; 116(1-2):81-6. PubMed ID: 2147983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 15. D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo.
    Consolo S; Girotti P; Zambelli M; Russi G; Benzi M; Bertorelli R
    Prog Brain Res; 1993; 98():201-7. PubMed ID: 7902591
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 17. Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Oct; 23(1):95-101. PubMed ID: 2960914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors.
    Fuxe K; von Euler G; Finnman UB; Agnati LF
    Acta Physiol Scand; 1989 Jun; 136(2):295-6. PubMed ID: 2528887
    [No Abstract]   [Full Text] [Related]  

  • 20. New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain.
    O'Boyle KM; Waddington JL
    Neuropharmacology; 1987 Dec; 26(12):1807-10. PubMed ID: 3501846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.